SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 82 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,820,000 | +1.4% | 6,974,854 | 0.0% | 0.29% | -1.0% |
| Q1 2016 | $3,766,000 | -39.8% | 6,974,854 | 0.0% | 0.29% | -16.1% |
| Q4 2015 | $6,260,000 | +10.8% | 6,974,854 | 0.0% | 0.35% | +27.9% |
| Q3 2015 | $5,650,000 | +107.1% | 6,974,854 | +669.6% | 0.27% | +124.8% |
| Q2 2015 | $2,728,000 | +84.6% | 906,263 | +50.2% | 0.12% | +65.8% |
| Q1 2015 | $1,478,000 | – | 603,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |